Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease

被引:25
|
作者
Abou-Karam, Nada [1 ,2 ]
Bradford, Chad [1 ,2 ]
Lor, Kajua B. [2 ]
Barnett, Mitchell [2 ]
Ha, Michelle [3 ]
Rizos, Albert [4 ]
机构
[1] Sharp Mem Hosp & Rehabil Ctr, Dept Pharm Serv, 7901 Frost St, San Diego, CA 92123 USA
[2] Touro Univ Calif, Dept Clin Sci, Coll Pharm, Vallejo, CA USA
[3] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[4] Sharp Healthcare, Syst Pharm Serv, San Diego, CA USA
来源
SAGE OPEN MEDICINE | 2016年 / 4卷
关键词
Medication regimen complexity index; readmission; re-hospitalization; acute care utilization; high-risk disease state;
D O I
10.1177/2050312116632426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Readmission rate is increasingly being viewed as a key indicator of health system performance. Medication regimen complexity index scores may be predictive of readmissions; however, few studies have examined this potential association. The primary objective of this study was to determine whether medication regimen complexity index is associated with all-cause 30-day readmission after admission for heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease. Methods: This study was an institutional review board-approved, multi-center, case-control study. Patients admitted with a primary diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease were randomly selected for inclusion. Patients were excluded if they discharged against medical advice or expired during their index visit. Block randomization was utilized for equal representation of index diagnosis and site. Discharge medication regimen complexity index scores were compared between subjects with readmission versus those without. Medication regimen complexity index score was then used as a predictor in logistic regression modeling for readmission. Results: Seven hundred and fifty-six patients were randomly selected for inclusion, and 101 (13.4%) readmitted within 30 days. The readmission group had higher medication regimen complexity index scores than the no-readmission group (p < 0.01). However, after controlling for demographics, disease state, length of stay, site, and medication count, medication regimen complexity index was no longer a significant predictor of readmission (odds ratio 0.99, 95% confidence interval 0.97-1.01) or revisit (odds ratio 0.99, 95% confidence interval 0.98-1.02). Conclusion: There is little evidence to support the use of medication regimen complexity index in readmission prediction when other measures are available. Medication regimen complexity index may lack sufficient sensitivity to capture an effect of medication regimen complexity on all-cause readmission.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Association of acute kidney injury with readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: a population-based study
    Atsushi Hirayama
    Tadahiro Goto
    Kohei Hasegawa
    BMC Nephrology, 21
  • [22] Taking a Closer Look: Factors That Impact Readmissions in Patients With Heart Failure, Acute Myocardial Infarction, and Pneumonia
    Centeno, M.
    Reed, J.
    CLINICAL NURSE SPECIALIST, 2013, 27 (02) : E50 - E50
  • [23] Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database
    Jacobs, David M.
    Noyes, Katia
    Zhao, Jiwei
    Gibson, Walter
    Murphy, Timothy F.
    Sethi, Sanjay
    Ochs-Balcom, Heather M.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (07) : 837 - 845
  • [24] Associations of medication regimen complexity with medication adherence and clinical outcomes in patients with chronic obstructive pulmonary disease: a prospective study
    He, Ruoxi
    Wang, Ye
    Ren, Xiaoxia
    Huang, Ke
    Lei, Jieping
    Niu, Hongtao
    Li, Wei
    Dong, Fen
    Li, Baicun
    Yang, Ting
    Wang, Chen
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [25] Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
    Cheng, Wei Erh
    Wu, Shan Chieh
    Chong, Sandy Ian-U.
    Chen, Jou Ying
    Lin, Hsiang-Wen
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [26] Management of Chronic Obstructive Pulmonary Disease Patients after Hospitalization for Acute Exacerbation
    Osthoff, Mirjam
    Leuppi, Joerg D.
    RESPIRATION, 2010, 79 (03) : 255 - 261
  • [27] What is the influence of chronic obstructive pulmonary disease in patients with acute myocardial infarction
    Santos, A. R.
    Picarra, B.
    Celeiro, M.
    Bento, A.
    Aguiar, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1082 - 1082
  • [28] Prognosis in patients with chronic obstructive pulmonary disease and acute heart failure
    Urdiales Ruano, E.
    Vazquez Alonso, E.
    Salvador Chuquipul, F. L.
    Vigal Garcia, N.
    Gil Espinosa, V
    Jacob Rodriguez, J.
    EMERGENCIAS, 2023, 35 (03): : 236 - 236
  • [29] Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
    Lawson, Claire A.
    Mamas, Mamas A.
    Jones, Peter W.
    Teece, Lucy
    McCann, Gerry
    Khunti, Kamlesh
    Kadam, Umesh T.
    JAMA NETWORK OPEN, 2018, 1 (08)
  • [30] Myocardial infarction and chronic obstructive pulmonary disease in the community
    Bursi, Francesca
    Vassallo, Robert
    Weston, Susan
    Killian, Jill
    Roger, Veronique
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A191 - A191